Dyadic International Inc at Roth Conference Transcript
Good morning, my name is Scott Henry, Healthcare Analyst at Roth MKM Partners. Thank you for joining this fireside chat. This will be webcast. Our focus company is Dyadic International, ticker DYAI. Approximately $50 million market cap company. Participating from the company is Mark Emalfarb, Chief Executive Officer. Let's get started. g
Mark, thank you for coming to the conference. Could you take a couple minutes, and I think you've got some slides, to just tell us about Dyadic. After that, we'll open it up for discussion. And we have about 25 minutes for this event.
Hi, Scott, great to see you again. Hi, that's much better. Anyway, it's great to see you again, Scott. So first of all, just to make it clear, we do not have money with Silicon Valley Bank. So that's a good thing for us, and we wish everyone the best.
Anyways, Dyadic is a biotech company that has a very interesting history, but our future is even brighter. So we've
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |